Clinical Trial Update: Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prophylactic tranexamic acid to reduce bleeding during minimally invasive myomectomy is in progress; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Fibroid Uterus

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Fibroid Uterus, Abnormal Uterine Bleeding | Phase 3 | Status: UNKNOWN